Does the dose do it?

Journal of Neurologic Physical Therapy

Volumn 33, Issue 4, 2009, Pages 177-178

  Field Fote, Edelle C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

EDITORIAL; EXERCISE; HUMAN; NEUROLOGIC DISEASE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE;

ARTERIAL OCCLUSIVE DISEASES; ASPIRIN; EXERCISE; GUIDELINES AS TOPIC; HUMANS; NERVOUS SYSTEM DISEASES; PLATELET AGGREGATION INHIBITORS;

EID: 73849114172     PISSN: 15570576     EISSN: 15570584     Source Type: Journal    
DOI: 10.1097/NPT.0b013e3181c29abc     Document Type: Editorial

References (6)

1. Antithrombotic Trialists' Collaboration, Baigent C, Blackwell L, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849-1860.
2. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39:1423-1434.
3. Lang CE, MacDonald JR, Gnip C. Counting repetitions: an observational study of outpatient therapy for people with hemiparesis post-stroke. J Neurol Phys Ther. 2007;31:3-10.
4. Michael KM, Allen JK, Macko RF. Reduced ambulatory activity after stroke: the role of balance, gait, and cardiovascular fitness. Arch Phys Med Rehabil. 2005;86:1552-1556.
5. Halder P, Sterr A, Brem S, et al. Electrophysiologic evidence for cortical plasticity with movement repetition. Eur J Neurosci. 2005;21:2271-2277.
6. Ward SR. Introduction of Dr. Reggie Edgerton at the Section on Research Retreat. Pacific Grove, CA. 9 Aug 2009.